Kashmolah Ghazi's Form 4 filing
Lucira Health, Inc. (LHDX) · filed Dec 9, 2022
- Accession no.
- 0001209191-22-060480
- Filed
- Dec 9, 2022, 4:15 PM ET
- Trade date
- Nov 17, 2022
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $12.4K. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kashmolah GhaziCIK 0001877741 | Officer (Ex VP & Chief Quality Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Common Stock | SSaleDisposed | −8,011 | $0.38 | −$3,044.18 | 171,876 | Direct | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −25,236 | $0.37 | −$9,337.32 | 146,640 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.